top of page
Development Pipeline
CÅ«rza has several distinct structural classes of small molecule therapeutics that are currently being prepared to enter the clinical phase of development.
We are also developing anti-biofilm antibiotics with various potential applications. Biofilms can cause some of the hardest to treat infections. Our antibiofilm compounds are exceptionally effective at killing and dispursing various types of biofilms.
bottom of page